Related by context. All words. (Click for frequent words.) 68 JAK3 67 hedgehog pathway 67 VEGF receptor 66 JAK2 66 MEK ERK 65 Wnt signaling pathway 65 cyclin dependent kinases 65 anticancer therapeutics 64 protein tyrosine phosphatase 1B 64 PKM2 64 mitotic kinesin 64 ENMD # 64 M2 subunit 64 Aurora kinase 64 mTOR mammalian target 64 siRNA therapeutic 64 small molecule modulators 63 Protein Kinase C 63 histone deacetylase HDAC 63 5 HT4 receptor 63 TLR8 63 Stapled Peptide 63 flavopiridol 63 Nanobodies ® 63 neurotrophic factor 63 Six3 63 immunotoxin 63 uPAR 63 novel peptides 63 TRAIL induced apoptosis 63 intracellular signaling pathways 63 monoclonal antibody mAb 63 epothilones 63 selectively inhibited 63 c MET 63 CCR1 63 A3 adenosine receptor 63 virus AAV 63 5 HT6 receptor 63 selective inhibition 63 Hypoxia Inducible Factor 62 intracellular protein 62 mda 7 62 metabotropic glutamate receptors 62 EGFR HER 62 GPR# [002] 62 Sphingomab 62 androgen receptor AR 62 EGF receptor 62 HDACs 62 P#X# 62 MAP kinase 62 humanized monoclonal antibodies 62 leukocyte adhesion 62 anionic backbone 62 telomerase inhibitor 62 immune modulating 62 Gamma secretase 62 histone deacetylases 62 effector function 62 Resten NG 62 Skp2 62 receptor tyrosine kinase inhibitor 62 ERK pathway 62 therapeutic monoclonal antibodies 62 protein kinase inhibitor 62 kidney urologic 62 THR beta agonist 62 thymidylate synthase TS 62 Curaxin 62 siRNA knockdown 62 5 HT2A serotonin 62 Nanobody 62 p# pathway 62 histone deacetylase inhibitors 62 SCD1 62 p# subunit 62 preclinically 62 targeting CD# 62 TTR gene 62 c Raf kinase 62 glucagon receptor 62 PI3K/mTOR 62 Smac mimetics 62 p# Shc 62 HCV protease 62 EGFR pathway 62 alpha folate receptor 62 HCV replication 61 Flt3 61 Epidermal Growth Factor Receptor 61 antisense inhibition 61 TLR9 agonists 61 rxRNA 61 antisense inhibitors 61 mGluR4 61 TLR9 agonist 61 cytoprotective 61 hypoxia inducible factor 61 CENP E 61 AT1R 61 inhibit metastasis 61 KuDOS 61 EGFR signaling 61 chemokine receptor 61 Th1 type 61 stem cell pluripotency 61 mGluR5 antagonist 61 p# MAPK 61 biased ligand 61 Talabostat 61 FLT3 61 cMET 61 novel therapeutic antibodies 61 alpha 2A adrenergic 61 MetAP2 61 engineered RAP peptides 61 IAP inhibitor 61 SIRT1 enzyme 61 Monoclonal antibody 61 CK2 61 PI3K inhibitor 61 CB2 receptor 61 EphA2 61 novel peptide 61 Nanobody ® 61 Vincent Mutel CEO 61 FGFR 61 taxane derivative 61 targeting PCSK9 61 miR #a [002] 61 LPA1 61 leukotriene pathway 61 Beta catenin pathway 61 lymphotoxin 61 PPARγ 61 cellular pathways 61 Janus Kinase 61 reversible inhibitor 61 endogenous ligands 61 immunostimulatory 61 AMPK activators 61 HCV NS5B polymerase 61 Epidermal Growth Factor 61 potent cytotoxic 61 tyrosine kinase inhibitor 61 adrenergic regulation 61 MT#/MEDI-# 61 cathepsins 61 Src kinases 61 ERK1 2 61 peptide antigens 61 chimeric monoclonal antibody 61 Systemic Delivery 61 #beta HSD1 60 lipid nanoparticle 60 sphingolipid 60 CCR3 60 NS5A 60 cellular signaling pathways 60 IGF IR 60 therapeutic monoclonal antibody 60 pharmacological inhibition 60 NS5b 60 DNA methyltransferases 60 FBPase 60 Akt activation 60 multi kinase inhibitor 60 humanized monoclonal 60 glycogen synthase kinase 60 Fibroblast Growth Factor Receptor 60 systemic RNAi 60 antitumor 60 eotaxin 60 Hedgehog signaling pathway 60 induces apoptosis 60 ubiquitin ligases 60 deacetylation 60 CCR9 60 E#F# 60 antibody mediated 60 Pten 60 hyperphosphorylation 60 neuronal nicotinic receptors NNRs 60 Trophos 60 HDAC inhibition 60 acetylcholinesterase AChE 60 PTP 1B 60 short hairpin RNAs 60 Bryostatin 60 biologic therapeutics 60 RONDEL TM 60 oncogenic signaling 60 Gleevec resistant 60 Ras pathway 60 γ secretase 60 Tyrima 60 oncomodulin 60 costimulatory 60 ADAMTS# 60 inhibit EGFR 60 NKG2D 60 GMX# 60 Tumor Necrosis Factor 60 thyroid hormone receptor 60 Cathepsin B 60 PI3K Akt 60 potently inhibit 60 glutamate receptors 60 investigational humanized monoclonal antibody 60 HCV NS3 protease 60 CCR9 antagonist 60 M1 muscarinic 60 UsiRNAs 60 serine threonine kinase 60 membrane receptors 60 PDE4 inhibitor 60 selective kinase inhibitor 60 immune modulatory 60 NF kB pathway 60 MAPK pathway 60 anti secretory 60 RANK ligand 60 MEK inhibitor 60 NS5B 60 RNA silencing 60 sphingosine 1 60 DiLA2 liposomes 60 myogenesis 60 specific lectin receptors 60 CDDO Im 60 short interfering RNA 60 #ß HSD1 60 histone deacetylase inhibitor 60 OTCBB NRGX 60 TGF beta1 60 vascular disrupting agents 60 pDCs 60 TGF ß 60 Nrf2 pathway 60 5 HT4 60 anticancer therapies 60 immune modulator 60 IGF 1R 60 cyclophilin D 60 Olaparib 60 CD#L 60 antitumor effects 60 PDGF receptor 59 antifibrotic 59 liposomal delivery 59 Anticalins ® 59 EZH2 59 chemically modified siRNA 59 HGS ETR1 mapatumumab 59 Pentraxin 2 59 Fc fusion protein 59 CXCR7 59 GRP# 59 IMiDs R 59 Symadex 59 soluble receptor 59 retinoblastoma protein 59 immunomodulatory properties 59 G Protein Coupled 59 TGF alpha 59 Neuropeptide Y 59 oral antiviral 59 neurite outgrowth 59 lectin pathway 59 humanized antibody 59 FGFR1 59 Atrasentan 59 antitumoral 59 AKT inhibitor 59 uPA 59 Notch receptor 59 rhIL 7 59 HQK 59 Blinatumomab 59 delivered RNAi therapeutic 59 Clusterin 59 metaglidasen 59 Receptors GPCRs 59 apoptotic pathway 59 neurofibromin 59 novel antiviral therapeutics 59 Nav#.# 59 RNA antagonists 59 poly ADP ribose polymerase 59 neuroprotective properties 59 HDAC inhibitors 59 oral prodrug 59 ProMune 59 Hedgehog pathway 59 Id1 59 TAT2 59 DGAT 59 PARP1 59 peptibody 59 C5aR 59 NKX#.# 59 metalloprotease 59 neuroinflammatory 59 AAV vector 59 DNA intercalator 59 HuCAL antibody 59 CYT# potent vascular disrupting 59 cyclic peptide 59 phosphate S1P 59 gamma secretase inhibitor 59 OMP #M# 59 protein encoded 59 vinca alkaloid 59 Factor VIIa 59 GeneICE 59 alpha#beta# integrin 59 adenosine A2A 59 vascular disrupting 59 anti CD3 59 NS#/#A protease 59 activin 59 mGluR2 NAM 59 JAK2 enzyme 59 potent inhibition 59 cannabinoid receptor 59 antimitotic 59 peptide hormone 59 RIP1 kinase 59 Kohwi Shigematsu 59 NTDDS 59 HIF 1alpha 59 Janus kinase 59 coupled receptor GPCR 59 siRNA mediated 59 protein kinases 59 NeuroTrans TM 59 ActivX 59 HIF 1α 59 Aurora Kinase 59 oral ghrelin agonist 59 TRIM5a 59 alpha#beta# 59 PTHrP 59 PI3 K 59 HTS assay 59 PKC# 59 PROfusion 59 proteasome inhibitor 59 thrombopoietin 59 oral JAK#/JAK# inhibitor 59 EGFR receptor 59 Maribavir 59 tubulin inhibitor 59 anti amnesic 59 HCV polymerase 59 myelofibrosis polycythemia vera 59 FGFR3 59 Cyclin D1 59 CTLA 4 59 tumor antigen 59 nanomedicines 59 prostaglandin synthesis 59 SIRT1 gene 59 angiogenesis inhibitor 59 Vaccinex 59 skeletal sarcomere activators 59 Pathway Inhibitor 59 VentiRx 59 Factor Receptor 59 Epothilones 59 isoform selective 59 potent inhibitors 59 Vidofludimus 59 thrombin receptor 59 NLRP3 59 siRNA therapeutics 59 oncolytic virus 59 lysophosphatidic acid LPA 59 LRP1 59 MEK inhibitors 59 recombinant antibodies 59 Cytotoxic T 59 arginase 59 GlgE 59 Affibody 59 AKT1 59 mTOR kinase 59 TGR5 59 pRb 59 Akt phosphorylation 59 XL# inhibits 59 anaphase promoting complex 59 Aviptadil 59 TGF beta pathway 59 RNAi therapeutic targeting 58 GATA3 58 fusion proteins 58 Akt3 58 pan HDAC inhibitor 58 IMA# 58 biased ligands 58 inhibiting angiogenesis 58 BNC# 58 BRAF kinase 58 anaplastic lymphoma kinase ALK 58 mineralocorticoid receptor 58 AEG# 58 adenosine receptor 58 PARP inhibition 58 autophagic 58 Akt1 58 oncolytic 58 siRNAs targeting 58 highly selective inhibitor 58 Bavituximab 58 phosphoinositide 3 58 Wnt pathway 58 adipogenic 58 proteasome inhibitors 58 TRAIL R2 58 potent anticancer 58 Panzem 58 lipid mediators 58 p# alpha [001] 58 enzyme inhibitor 58 DGAT1 58 Creabilis Therapeutics 58 optimized siRNA 58 MIF protein 58 c Abl 58 blood clotting protein 58 GRN# 58 cell adhesion molecule 58 selectively inhibits 58 anti fibrotic 58 exon skipping 58 IGF1R 58 TAp# 58 TLR9 58 small molecule agonists 58 β catenin 58 oral JAK1 58 abnormal p# 58 NFκB 58 HepDirect prodrug 58 small molecule tyrosine 58 protein CETP 58 SIRT3 58 peptidic compound 58 introduced NEUGENE 58 NNRs 58 Enzastaurin 58 ESBA# 58 engineered proteases 58 Calando proprietary 58 aP2 58 NFkappaB 58 Zalypsis 58 novel anticancer 58 small interfering RNA 58 PML RARA 58 liposomal formulation 58 apoptosis proteins 58 Seliciclib 58 antibody MAb 58 histone acetylation 58 mitogen activated protein kinase 58 CYP# [002] 58 DNA gyrase 58 NS4B 58 FUS1 58 3 kinase PI3K 58 post transcriptional 58 Notch receptors 58 C5a 58 Survivin antagonist 58 mGluR2 58 CCR2 58 MGd 58 Tarvacin TM 58 HDAC enzymes 58 JAK1 58 biologic pathway 58 aurora kinase inhibitor 58 TNFα 58 Y2 receptor 58 NRG1 58 PI3 kinase 58 Sapacitabine 58 chemokine 58 p# inhibitor 58 adult mesenchymal stem 58 intracellular accumulation 58 PDE# 58 cystic fibrosis transmembrane conductance 58 protein kinase C 58 tumor suppressor protein 58 lipid nanoparticles 58 hedgehog signaling pathway 58 SOCS1 58 mertansine 58 mTOR signaling pathway 58 JAK inhibitors 58 pathophysiological effects 58 inverse agonist 58 receptor alpha 58 Bafetinib 58 immuno modulatory 58 Fc receptor 58 resolvins 58 auristatin 58 focal adhesion kinase FAK 58 PSN# [002] 58 cytokine receptor 58 Notch signaling pathway 58 siRNA binds 58 EphB2 58 NFkB 58 INGN 58 Ep CAM 58 Nod1 58 antiapoptotic 58 CDK4 58 OMP #R# 58 S1P 58 CBLC# 58 bioactive lipids 58 lipid nanoparticle LNP 58 PI3K pathway 58 PLX MS 58 molecularly targeted 58 c MYC 58 vivo validation 58 inhibit viral replication 58 IL 1β 58 cytostatic 58 Abiraterone 58 microRNA miR 58 CEQ# 58 HepDirect technology 58 Tumour Vascular Disrupting Agent 58 IAP inhibitors 58 effector functions 58 sclerostin 58 intratumoral injection 58 diphtheria toxin 58 STAT3 signaling 58 secretory phospholipase A2 58 E1A 58 TRAF6 58 GSK3 58 factor HGF 58 calcineurin 58 NSCLC tumors 58 FoldRx Pharmaceuticals Inc. 58 neurotrophic 58 HepDirect 58 Omacetaxine 58 COX2 58 muscle contractility 58 endostatin 58 apricitabine ATC 58 SGLT2 58 peroxisomal 58 antisense drug 58 MMP9 58 depsipeptide 58 Anticalins R 58 receptor tyrosine kinase 58 LRP5 58 Receptos 58 agonistic human 58 CD# monoclonal antibody 58 PDE# inhibitors 58 ligases 58 histone modification 58 ALN HTT 58 selective modulator 58 activate SIRT1 58 antibody fragment 58 oral Janus kinase 58 RNAi mediated 58 Pertuzumab 58 JAK inhibitor 58 Novosom 58 incretin 58 Protein Kinase 58 Galectins 58 PGE2 58 Sudhir Agrawal D.Phil 58 proapoptotic 58 histone deacetylase 58 antiproliferative effects 58 CDK inhibitors 58 Tß4 58 5 HT2A inverse 58 Adenosine Therapeutics 58 MAPK 58 talabostat 57 VEGFR2 57 Epratuzumab 57 Mucosal 57 Squalamine 57 Lisofylline LSF 57 BRAF inhibitor 57 orally bioavailable 57 multikinase inhibitor 57 RNA ribonucleic acid 57 Plasmid DNA 57 Ercole Biotech 57 HSP# inhibitors 57 virulence genes 57 RANKL 57 AtuPLEX 57 antisense drugs 57 lymphangiogenesis 57 PROCHYMAL 57 Elvitegravir 57 MTP inhibitor 57 intracellular signaling 57 PDGFR 57 ATL# [001] 57 Wnt signaling 57 Sym# 57 JAK2 inhibitor 57 hepatic stellate cells 57 PKC isoforms 57 mitogen 57 small molecule glucokinase 57 kinase pathway 57 vascular disrupting agent 57 ubiquitin ligase 57 IL #p# 57 nicotinic alpha 7 57 PKC enzyme 57 Vegenics 57 Epstein Barr Virus EBV 57 ChR2 57 dihydrofolate reductase 57 Reports Preclinical Data 57 signal transduction 57 potently inhibited 57 TLR7 57 Adnectin 57 SIX RO ROG 57 glucokinase 57 selective antagonists 57 PARP inhibitor 57 romazarit 57 Wnt beta catenin 57 RNAi pathway 57 humanised monoclonal antibody 57 inhibit angiogenesis 57 Enkephalin 57 DepoVax 57 mTOR pathway 57 Chemokine 57 SGLT Inhibitors 57 Locked Nucleic Acid 57 protein p# 57 orally administered inhibitor 57 deacetylase inhibitors 57 GRNOPC1 contains 57 plasma kallikrein 57 Crizotinib 57 p#Kip# 57 HER3 57 5 HT2A receptor 57 OncoVex 57 LHRH antagonists 57 PNP inhibitor 57 Angiolix 57 trastuzumab resistant 57 serine proteases 57 UsiRNA 57 Anticalin R 57 selectively inhibit 57 glucocorticoid receptors 57 molecular abnormalities 57 secretory phospholipase A2 sPLA2 57 methyl D aspartate 57 matrix metalloproteinases MMPs 57 Hedgehog signaling 57 mTOR inhibition 57 transient receptor 57 bacterial enzyme 57 Monoclonal Antibody 57 Raf kinase 57 lipid synthesis 57 gastro intestinal inflammation 57 Guanilib 57 Nanobody R 57 receptor monoclonal antibody 57 ADAM# 57 pancreatic islet beta 57 PHD2 57 systemically administered 57 polysaccharide polymer 57 ERBB4 57 Curaxins 57 LKB1 57 Upregulation 57 COX enzymes 57 TSP1 57 IGFBP2 57 BRAF protein 57 proprietary biomaterials 57 immatics 57 stable nucleic acid 57 PPARg 57 Locked Nucleic Acid LNA 57 antiangiogenesis 57 antisense inhibitor 57 HDAC2 57 HSP# inhibitor 57 PKC alpha 57 biologic pathways 57 ZNF# 57 RAF kinase VEGFR 57 ERK signaling 57 HGS# 57 neurotrophic factors 57 ß catenin 57 small molecule thrombopoietin 57 inhibiting mTOR 57 PARP inhibitors 57 ribonucleotide reductase clinically validated 57 potent antiproliferative 57 angiogenesis inhibition 57 non coding RNA 57 signal transduction inhibitor 57 PI3K signaling pathway 57 molecular pathway 57 ANG# 57 PTP1B 57 abnormal angiogenesis 57 OncoVEX 57 STAT3 57 neuroblastoma tumors 57 proto oncogene 57 fusion enhancers 57 4SC AG ISIN DE# 57 antisense compounds 57 ligand TRAIL 57 PI3 Kinase 57 PEDF 57 glioblastoma cells 57 intracellularly 57 YONDELIS 57 carcinoembryonic antigen 57 PLK1 57 novel VDA molecule 57 LRP6 57 renal fibrosis 57 MAbs targeting 57 tranilast 57 STK# [002] 57 insertional mutagenesis 57 solithromycin 57 nicotinic acetylcholine receptor 57 NuMimetic TM 57 signal transduction inhibitors 57 Tarvacin Anti Viral 57 beta1 integrin 57 anti angiogenic agent 57 targeted radiotherapeutic 57 plasmid DNA pDNA 57 Signal transduction 57 receptor modulators 57 vWF 57 Aptamer 57 cardio metabolic diseases 57 FGFR4 57 Ets2 57 ischemic tissues 57 protein tyrosine kinase 57 pharmacological chaperone 57 Saegis Pharmaceuticals 57 casein kinase 57 lysosomal enzyme 57 melanocortin receptors 57 factor receptor FGFR 57 neurotrophins 57 MCSP respectively 57 GGF2 57 aberrantly activated 57 BMP4 57 NF κB 57 Galectin 57 OGG1 57 carbohydrate antigens 57 Dr. Dinarello 57 tumor vascular disrupting 57 apoptosis inducing 57 sd rxRNA 57 cellular immunotherapy 57 mRNA decay 57 nucleoside analogues 57 novel immunomodulatory 57 Panzem NCD 57 telomerase therapeutic 57 kinase inhibitor 57 prostaglandin D2 57 antisense oligonucleotide 57 fibrotic disease 57 interferon lambda 57 splice variant 57 HIF 1a 57 RRM1 57 Nurr1 57 microtubule inhibitor 57 viral proteins 57 mTOR inhibitors 57 oncogenesis 57 Carfilzomib 57 polymerase inhibitor 57 huC# DM4 57 tenascin C 57 Aurora kinase inhibitor 57 Spiegelmer 57 ALS #-# 57 synthetic retinoid 57 small molecule inhibitors 57 PF # [002] 57 Kinase 57 pro apoptotic 57 SAR# [004] 57 Yap1 57 ESPRIT therapy 57 selectively inhibiting 57 VitiGam 57 Inotek 57 anticancer activity 57 prostanoid 57 HER1 57 Phylomer ® 57 atacicept 57 experimentally validated 57 PPAR alpha 57 anti proliferative 57 MLL2 57 Aplidin 57 Bcr Abl 57 Santaris 57 Novel Antibody 57 retinoid X 57 MAP kinase pathway 57 cAMP signaling 57 replicon 57 c myb 57 potent anti angiogenic 57 ALN TTR 57 Oncogenic 57 peptide therapeutics 57 selective antagonist 57 DiLA2 57 synovial cells 57 EGF receptors 57 antagomirs 57 CA4P 57 Hh pathway 57 microRNA molecules 57 lentiviral vector 57 ddRNAi 57 Wellstat 57 IgG1 antibody 57 osteopontin OPN 57 neuropilin 57 murine monoclonal antibody 57 HCV protease inhibitors 57 glutamate signaling 57 TNFa 57 antiviral compounds 57 FOXP3 56 gene silencing 56 Cylene 56 apoE 56 TLE3 56 ENaC 56 Glypromate 56 ribonuclease 56 novel immunotherapies 56 acetylcholine receptor 56 pertuzumab 56 JAK#/JAK# 56 inhibit replication 56 HDAC6 56 CYC# 56 siRNA molecules 56 Immunohistochemical analysis 56 bioactive lipid 56 FoldRx 56 Taligen Therapeutics 56 sodium glucose cotransporter 56 GCN2 56 mammaglobin 56 PSMA ADC 56 DNMT1 56 nanocarrier 56 PPAR gamma 56 IFN γ 56 CTGF 56 immune stimulatory 56 Notch pathway 56 vascular endothelial cells 56 phosphoprotein 56 antimetastatic 56 c myc 56 GRN#L 56 allosteric modulation 56 CaM kinase II 56 targeted antifolate 56 SAR# [002] 56 RAS MAPK pathway 56 small molecule activator 56 FasL 56 somatostatin receptors 56 axonal regeneration 56 cytokines IL 56 micro RNA 56 CDKs 56 myeloproliferative disorders 56 RAS pathway 56 interleukins 56 FGFR2 56 PAR1 56 PRLX # 56 Agios Pharmaceuticals 56 MET amplification 56 beta arrestin 56 favorable pharmacokinetic profile 56 detection reagents 56 eIF 4E 56 fosbretabulin 56 Cobalamin TM mediated 56 NITD# 56 tumor vasculature 56 tyrosine kinase receptor 56 enzymatic pathway 56 mutational status 56 molecular determinants 56 TMEM#B 56 pro angiogenic 56 Protease inhibitors 56 glial derived neurotrophic 56 transgenic mouse models 56 M1 macrophages 56 Cotara ® 56 MAP kinases 56 STAT1 56 nanoparticle aggregates 56 transthyretin TTR 56 EGFR HER2 56 peroxisome proliferator activated 56 candidate deforolimus 56 tipifarnib 56 vaccine GRNVAC1 56 sublingual route 56 prodrugs 56 MKC# MKC# PP 56 HuLuc# 56 IL# PE#QQR 56 Stat3 56 nNOS 56 CaR 56 HER2 receptors 56 BCL2 56 matrix metalloproteases 56 anti EGFR antibody 56 K ras mutations 56 radiolabeled monoclonal antibody 56 Virulizin ® 56 proteinase 56 MicroRNA 56 cultured stem cells 56 geldanamycin 56 ALK inhibitors 56 PTPN# 56 miRagen 56 PCSK9 56 GVAX ® 56 beta defensins 56 acetylcholinesterase 56 hormone gastrin 56 clusterin 56 JVRS 56 pathogenic mechanisms 56 survivin 56 Oligonucleotide 56 anti inflammatory cytokine 56 TORC2 56 EGFR inhibitors 56 aldose reductase 56 NRGN 56 anticancer agents 56 experimental autoimmune encephalomyelitis 56 EC Cysteamine 56 Litx